35 related articles for article (PubMed ID: 10637473)
21. The prognostic potential of bone marrow cyclin E and P27, in Egyptian patients with acute myeloid leukemia.
Abdel Alim A; Youssef SR; Farouk HM
Egypt J Immunol; 2010; 17(1):9-18. PubMed ID: 22053605
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
[TBL] [Abstract][Full Text] [Related]
23. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
Cote RJ; Shi Y; Groshen S; Feng AC; Cordon-Cardo C; Skinner D; Lieskovosky G
J Natl Cancer Inst; 1998 Jun; 90(12):916-20. PubMed ID: 9637141
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure.
Radosevic N; Delmer A; Tang R; Marie JP; Ajchenbaum-Cymbalista F
Leukemia; 2001 Apr; 15(4):559-66. PubMed ID: 11368357
[TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia.
Yokozawa T; Towatari M; Iida H; Takeyama K; Tanimoto M; Kiyoi H; Motoji T; Asou N; Saito K; Takeuchi M; Kobayashi Y; Miyawaki S; Kodera Y; Ohno R; Saito H; Naoe T
Leukemia; 2000 Jan; 14(1):28-33. PubMed ID: 10637473
[TBL] [Abstract][Full Text] [Related]
27. [Constitutive activation of MAP kinase pathway and STAT pathway in AML].
Towatari M; Iida H
Rinsho Ketsueki; 1998 Feb; 39(2):86-8. PubMed ID: 9545805
[No Abstract] [Full Text] [Related]
28. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
29. Prognostic markers in acute leukemia.
Leith CP; Willman CL
Curr Opin Hematol; 1996 Jul; 3(4):329-34. PubMed ID: 9372096
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
